FCG Investment Co Sells 20,777 Shares of Oscar Health, Inc. (NYSE:OSCR)

FCG Investment Co trimmed its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 44.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,728 shares of the company’s stock after selling 20,777 shares during the quarter. FCG Investment Co’s holdings in Oscar Health were worth $346,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of OSCR. Whalen Wealth Management Inc. bought a new position in shares of Oscar Health in the fourth quarter worth approximately $670,000. Janney Montgomery Scott LLC boosted its position in Oscar Health by 24.2% during the 4th quarter. Janney Montgomery Scott LLC now owns 57,850 shares of the company’s stock valued at $778,000 after buying an additional 11,282 shares during the period. Rolek Wealth Management LLC bought a new stake in Oscar Health in the 4th quarter worth $208,000. Hennessy Advisors Inc. increased its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after acquiring an additional 3,544,300 shares during the period. Finally, Harbor Capital Advisors Inc. raised its stake in shares of Oscar Health by 39.9% during the fourth quarter. Harbor Capital Advisors Inc. now owns 128,167 shares of the company’s stock valued at $1,723,000 after acquiring an additional 36,577 shares during the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Oscar Health news, insider Mario Schlosser sold 6,516 shares of the business’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the sale, the insider now directly owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. The trade was a 7.36 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Vice Chairman Joshua Kushner purchased 358,619 shares of Oscar Health stock in a transaction dated Wednesday, November 13th. The shares were bought at an average price of $13.74 per share, with a total value of $4,927,425.06. Following the completion of the acquisition, the insider now directly owns 5,810,700 shares of the company’s stock, valued at approximately $79,839,018. This represents a 6.58 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Stock Up 1.1 %

NYSE OSCR opened at $16.44 on Friday. The stock’s 50 day moving average is $15.19 and its 200 day moving average is $16.81. Oscar Health, Inc. has a twelve month low of $11.38 and a twelve month high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s quarterly revenue was up 68.3% on a year-over-year basis. During the same quarter last year, the firm posted ($0.29) EPS. On average, equities analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on OSCR shares. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price on the stock. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 target price for the company. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.